Variability of the Symptoms of Chronic Abacterial Prostatitis/Chronic Pelvic Pain Syndrome during Intermittent Therapy with Rectal Prednisolone Foam for Ulcerative Colitis

We describe the response of symptoms of chronic abacterial prostatitis/chronic pelvic pain syndrome (CAP/PPS) in a man treated with rectal prednisolone for concomitant ulcerative colitis. The temporal relationship of the symptoms of CAP/PPS to starting and stopping the topical corticosteroid over 2...

Full description

Saved in:
Bibliographic Details
Published in:International journal of STD & AIDS 2001-11, Vol.12 (11), p.752-753
Main Authors: Talbot, Martin, Bates, Sylvia
Format: Article
Language:English
Subjects:
Adult
Anti-Inflammatory Agents - administration & dosage
Anti-Inflammatory Agents - adverse effects
Anti-Inflammatory Agents - therapeutic use
Biological and medical sciences
Chronic Disease
Colitis, Ulcerative - complications
Colitis, Ulcerative - drug therapy
Drug toxicity and drugs side effects treatment
Glucocorticoids - administration & dosage
Glucocorticoids - adverse effects
Glucocorticoids - therapeutic use
Humans
Male
Medical sciences
Pelvic Pain - complications
Pelvic Pain - physiopathology
Pharmacology. Drug treatments
Prednisolone - administration & dosage
Prednisolone - adverse effects
Prednisolone - therapeutic use
Prostatitis - complications
Prostatitis - physiopathology
Rectum
Self-Examination
Syndrome
Toxicity: urogenital system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We describe the response of symptoms of chronic abacterial prostatitis/chronic pelvic pain syndrome (CAP/PPS) in a man treated with rectal prednisolone for concomitant ulcerative colitis. The temporal relationship of the symptoms of CAP/PPS to starting and stopping the topical corticosteroid over 2 treatment cycles lends further anecdotal support to our hypothesis that treatment of the immune-mediated response in this chronic condition has a beneficial effect upon symptomatic outcome.
ISSN:0956-4624
1758-1052
DOI:10.1258/0956462011924137